• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性吗啡处理及戒断对大鼠脑内RNA修饰m⁶A及其调控酶的研究

An Investigation of the RNA Modification mA and Its Regulatory Enzymes in Rat Brains Affected by Chronic Morphine Treatment and Withdrawal.

作者信息

Hronova Anna, Pritulova Eliska, Hejnova Lucie, Novotny Jiri

机构信息

Department of Physiology, Faculty of Science, Charles University, 128 00 Prague, Czech Republic.

出版信息

Int J Mol Sci. 2025 May 4;26(9):4371. doi: 10.3390/ijms26094371.

DOI:10.3390/ijms26094371
PMID:40362608
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12072463/
Abstract

N6-methyladenosine (mA) is one of the most prevalent methylated modifications of mRNA in eukaryotes. This reversible alteration can directly or indirectly influence biological functions, including RNA degradation, translation, and splicing. This study investigates the impact of chronic morphine administration and varying withdrawal durations (1 day, 1 week, 4 weeks, and 12 weeks) on the mA modification levels in brain regions critical to addiction development and persistence. Our findings indicate that in the prefrontal cortex, the mA levels and METTL3 expression decrease, accompanied by an increase in FTO and ALKBH5 expression, followed by fluctuating, but statistically insignificant changes in methylation-regulating enzymes over prolonged withdrawal. In the striatum, reductions in mA levels and METTL3 expression are observed at 4 weeks of withdrawal, preceded by non-significant fluctuations in enzyme expression and the mA modification levels. In contrast, no changes in the mA modification levels or the expression of related enzymes are detected in the hippocampus and the cerebellum. Our data suggest that mA modification and its regulatory enzymes undergo region-specific and time-dependent changes in response to chronic morphine exposure and subsequent withdrawal.

摘要

N6-甲基腺苷(mA)是真核生物中mRNA最普遍的甲基化修饰之一。这种可逆性改变可直接或间接影响生物学功能,包括RNA降解、翻译和剪接。本研究调查了长期给予吗啡以及不同戒断时长(1天、1周、4周和12周)对成瘾发展和持续存在至关重要的脑区中mA修饰水平的影响。我们的研究结果表明,在额叶前皮质中,mA水平和METTL3表达降低,同时FTO和ALKBH5表达增加,随后在长期戒断过程中,甲基化调节酶出现波动,但无统计学意义的变化。在纹状体中,戒断4周时观察到mA水平和METTL3表达降低,之前酶表达和mA修饰水平有不显著的波动。相比之下,在海马体和小脑中未检测到mA修饰水平或相关酶表达的变化。我们的数据表明,mA修饰及其调节酶在慢性吗啡暴露及随后的戒断反应中会发生区域特异性和时间依赖性变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c10c/12072463/1e8c713ff630/ijms-26-04371-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c10c/12072463/f037913011f8/ijms-26-04371-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c10c/12072463/e5ae32f723de/ijms-26-04371-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c10c/12072463/45a1ef96dc35/ijms-26-04371-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c10c/12072463/33a414e185a8/ijms-26-04371-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c10c/12072463/1e8c713ff630/ijms-26-04371-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c10c/12072463/f037913011f8/ijms-26-04371-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c10c/12072463/e5ae32f723de/ijms-26-04371-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c10c/12072463/45a1ef96dc35/ijms-26-04371-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c10c/12072463/33a414e185a8/ijms-26-04371-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c10c/12072463/1e8c713ff630/ijms-26-04371-g005.jpg

相似文献

1
An Investigation of the RNA Modification mA and Its Regulatory Enzymes in Rat Brains Affected by Chronic Morphine Treatment and Withdrawal.慢性吗啡处理及戒断对大鼠脑内RNA修饰m⁶A及其调控酶的研究
Int J Mol Sci. 2025 May 4;26(9):4371. doi: 10.3390/ijms26094371.
2
METTL3 and ALKBH5 oppositely regulate mA modification of mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes.METTL3 和 ALKBH5 对 mRNA 的 mA 修饰起相反调控作用,从而决定了低氧/复氧处理的心肌细胞的命运。
Autophagy. 2019 Aug;15(8):1419-1437. doi: 10.1080/15548627.2019.1586246. Epub 2019 Mar 17.
3
mA modification impacts hepatic drug and lipid metabolism properties by regulating carboxylesterase 2.mA 修饰通过调节羧酸酯酶 2 影响肝脏药物和脂质代谢特性。
Biochem Pharmacol. 2021 Nov;193:114766. doi: 10.1016/j.bcp.2021.114766. Epub 2021 Sep 16.
4
Cigarette smoking modulates mA modification, affecting the induction of CYP1A1 mRNA by regulating human ARNT and AHRR in A549 cells.吸烟可调节甲基化修饰,通过调控A549细胞中的人芳烃核转运蛋白(ARNT)和芳烃受体阻遏蛋白(AHRR)来影响细胞色素P450 1A1(CYP1A1)mRNA的诱导。
Toxicol Lett. 2025 May 1;407:41-49. doi: 10.1016/j.toxlet.2025.03.005. Epub 2025 Mar 19.
5
Dynamic multilayered control of mA RNA demethylase activity.动态多层控制 mA RNA 去甲基化酶活性。
Proc Natl Acad Sci U S A. 2024 Nov 12;121(46):e2317847121. doi: 10.1073/pnas.2317847121. Epub 2024 Nov 4.
6
The dual role of N6-methyladenosine modification of RNAs is involved in human cancers.RNA 中 N6-甲基腺苷修饰的双重作用与人类癌症有关。
J Cell Mol Med. 2018 Oct;22(10):4630-4639. doi: 10.1111/jcmm.13804. Epub 2018 Jul 24.
7
NADP modulates RNA mA methylation and adipogenesis via enhancing FTO activity.烟酰胺腺嘌呤二核苷酸磷酸(NADP)通过增强脂肪量和肥胖相关蛋白(FTO)的活性来调节RNA N6-甲基腺嘌呤(mA)甲基化及脂肪生成。
Nat Chem Biol. 2020 Dec;16(12):1394-1402. doi: 10.1038/s41589-020-0601-2. Epub 2020 Jul 27.
8
Morphine-Driven m6A Epitranscriptomic Neuroadaptations in Primary Cortical Cultures.吗啡驱动的原发性皮质培养物中的 m6A 表遗传神经适应
Mol Neurobiol. 2024 Dec;61(12):10684-10704. doi: 10.1007/s12035-024-04219-z. Epub 2024 May 23.
9
RNA m6A modification, signals for degradation or stabilisation?RNA的m6A修饰:降解信号还是稳定信号?
Biochem Soc Trans. 2024 Apr 24;52(2):707-717. doi: 10.1042/BST20230574.
10
FTO-Dependent -Methyladenosine Modifications Inhibit Ovarian Cancer Stem Cell Self-Renewal by Blocking cAMP Signaling.FTO 依赖性 -m6A 修饰通过阻断 cAMP 信号抑制卵巢癌细胞干细胞自我更新。
Cancer Res. 2020 Aug 15;80(16):3200-3214. doi: 10.1158/0008-5472.CAN-19-4044. Epub 2020 Jun 30.

本文引用的文献

1
ALKBH5 acts a tumor-suppressive biomarker and is associated with immunotherapy response in hepatocellular carcinoma.ALKBH5作为一种肿瘤抑制生物标志物,与肝细胞癌的免疫治疗反应相关。
Sci Rep. 2025 Jan 2;15(1):55. doi: 10.1038/s41598-024-84050-7.
2
RNA mA methyltransferase activator affects anxiety-related behaviours, monoamines and striatal gene expression in the rat.RNA mA甲基转移酶激活剂影响大鼠的焦虑相关行为、单胺类物质及纹状体基因表达。
Acta Neuropsychiatr. 2024 Oct 9;37:e52. doi: 10.1017/neu.2024.36.
3
Morphine-Driven m6A Epitranscriptomic Neuroadaptations in Primary Cortical Cultures.
吗啡驱动的原发性皮质培养物中的 m6A 表遗传神经适应
Mol Neurobiol. 2024 Dec;61(12):10684-10704. doi: 10.1007/s12035-024-04219-z. Epub 2024 May 23.
4
Long-term administration of morphine specifically alters the level of protein expression in different brain regions and affects the redox state.长期使用吗啡会特异性地改变不同脑区的蛋白质表达水平,并影响氧化还原状态。
Open Life Sci. 2024 Apr 20;19(1):20220858. doi: 10.1515/biol-2022-0858. eCollection 2024.
5
No significant change of N -methyladenosine modification landscape in mouse brain after morphine exposure.吗啡暴露后小鼠大脑中N-甲基腺苷修饰图谱无显著变化。
Brain Behav. 2024 Jan;14(1):e3350. doi: 10.1002/brb3.3350.
6
tRNA epitranscriptomic alterations associated with opioid-induced reward-seeking and long-term opioid withdrawal in male mice.与雄性小鼠阿片类药物诱导的觅药行为和长期阿片类药物戒断相关的 tRNA 表转录组改变。
Neuropsychopharmacology. 2024 Jul;49(8):1276-1284. doi: 10.1038/s41386-024-01813-6. Epub 2024 Feb 8.
7
METTL14-mediated m6A epitranscriptomic modification contributes to chemotherapy-induced neuropathic pain by stabilizing GluN2A expression via IGF2BP2.METTL14 通过 IGF2BP2 稳定 GluN2A 表达介导的 m6A 转录后修饰促进化疗诱导的神经性疼痛。
J Clin Invest. 2024 Feb 6;134(6):e174847. doi: 10.1172/JCI174847.
8
ALKBH5 is a prognostic factor and promotes the angiogenesis of glioblastoma.ALKBH5 是一个预后因素,并促进胶质母细胞瘤的血管生成。
Sci Rep. 2024 Jan 14;14(1):1303. doi: 10.1038/s41598-024-51994-9.
9
Globally reduced N-methyladenosine (mA) in C9ORF72-ALS/FTD dysregulates RNA metabolism and contributes to neurodegeneration.全球范围内 C9ORF72-ALS/FTD 中的 N6-甲基腺苷(m6A)减少会导致 RNA 代谢失调,并导致神经退行性变。
Nat Neurosci. 2023 Aug;26(8):1328-1338. doi: 10.1038/s41593-023-01374-9. Epub 2023 Jun 26.
10
The Regulatory Network of METTL3 in the Nervous System: Diagnostic Biomarkers and Therapeutic Targets.METTL3 在神经系统中的调控网络:诊断生物标志物和治疗靶点。
Biomolecules. 2023 Apr 11;13(4):664. doi: 10.3390/biom13040664.